By Fineline Cube 
B. Braun Medical Inc., a US-based healthcare company, announced that the U.S. Food and Drug Administration (FDA) has approved the use of piperacillin and tazobactam in its DUPLEX drug delivery system. This approval paves the way for a full market launch of the innovative system, designed to streamline antibiotic administration in healthcare settings.
Product Innovation
The DUPLEX system offers a ready-to-use, dual-chamber format for piperacillin and tazobactam, one of the most widely used injectable antibiotic combinations in the United States. The system keeps the antibiotic and diluent in separate compartments until immediately before use, simplifying preparation and reducing the risk of dosing errors.
Clinical Workflow Benefits
Healthcare providers can now prepare the medication bedside by simply folding, compressing, and shaking the container, achieving rapid reconstitution. This innovative design reduces medication preparation time by approximately four minutes per dose compared to conventional methods like Baxter’s Mini-Bag Plus system. The time savings translate to significant workflow efficiencies, enhancing clinical productivity and patient care.-Fineline Info & Tech